Archives
-
ASB5 Marks Muscle Satellite Cells but Is Dispensable
2026-10-02
The reference study identifies ASB5 as an abundant and specific marker of muscle satellite cells and myogenic progenitors, while showing that its loss does not impair normal muscle development, growth, satellite-cell behavior, or acute regeneration in mice. Its central contribution is to separate marker identity from functional necessity through single-cell analysis, germline CRISPR-Cas9 knockout, ex vivo assays, and molecular readouts.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-10-01
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than solely a GABA clearance mechanism. Its combination of electrophysiology, calcium signaling, optogenetics, and behavioral analysis links GABA uptake to GluN2B-dependent excitation and contextual fear memory, providing a framework for dissecting glia-neuron interactions.
-
Recombinant Human FGF-19 Workflow
2026-10-01
Recombinant Human FGF-19 provides a defined, tag-free ligand for FGFR4-oriented binding, proliferation, and metabolic regulation research. This guide covers reconstitution, assay controls, storage, and troubleshooting, while distinguishing product-validated activity from applications that require independent model-specific validation.
-
Gepotidacin: From DNA Breaks to Assay Design
2026-09-30
Gepotidacin (GSK2140944) is a first-in-class topoisomerase inhibitor whose unusual single-strand cleavage profile changes how antibacterial assays should be designed. This evidence-led guide connects structural mechanism, endpoint selection, resistance research, and translational interpretation.
-
PERK-Driven Pyroptosis in Disc Degeneration
2026-09-30
The reference study identifies a PERK/eIF2α/ATF4-dependent JAK1–STAT3 pathway that links unresolved endoplasmic reticulum stress to pyroptosis and inflammatory signaling in nucleus pulposus cells. Its experimental framework provides a useful basis for ER stress research and for testing whether selective PERK inhibition can interrupt disc-degeneration-associated inflammation.
-
Mitochondrial IRF3 in Bleomycin Lung Fibrosis
2026-09-29
The reference study identifies mitochondrial translocation of activated IRF3 as a mechanistic link between cGAS-STING signaling, defective mitophagy, ferroptosis, and pulmonary fibrosis. Its combination of mouse, epithelial-cell, biochemical, imaging, and flux-based assays provides a useful framework for dissecting how inflammatory signaling becomes mitochondrial injury.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-09-29
This study shows that astrocytic GAT-3 is an active regulator of dentate gyrus synaptic transmission, linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-NMDAR activity, and contextual fear-memory formation. Its multimodal design provides a useful framework for studying neuron–astrocyte interactions while clarifying how pharmacological controls can distinguish transporter-mediated signaling from receptor-mediated GABA effects.
-
4-MUG for Lysosomal Enzyme Activity Assays
2026-09-28
4-MUG converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent readout suited to lysosomal disease models, enzyme kinetics, and screening. This practical guide connects assay design with recent GBA1 mRNA research while emphasizing calibration, workflow controls, and troubleshooting.
-
Exo1 for Exocytosis Assays: Workflow & Insights
2026-09-28
Exo1 offers an acute way to probe Golgi-to-ER traffic and distinguish ARF1-linked effects from some actions of Brefeldin A. This practical guide shows how to build a controlled exocytosis assay—and how to connect trafficking readouts to tumor extracellular-vesicle research without overstating what Exo1 has been shown to do.
-
15-PGDH Inhibition Supports Muscle Repair During Weight Loss
2026-09-27
A 2026 PNAS mouse study reports that inhibiting 15-PGDH improves muscle stem-cell activity, regenerated muscle-fiber growth, and strength recovery during semaglutide-associated weight loss. The findings suggest a potential way to address muscle-repair deficits while retaining weight-loss effects, but they do not establish clinical benefit or a human treatment strategy.
-
MLN4924 and CRL5–APC/C Crosstalk in Cancer
2026-09-26
MLN4924 is a selective NEDD8-activating enzyme inhibitor for probing how neddylation shapes ubiquitin-ligase activity. This article connects its broad pathway effects to emerging CRL5–APC/C crosstalk and shows how that distinction can sharpen cancer biology experiments.
-
Coumestrol in Cell Assays: A Practical Design Guide
2026-09-25
This scenario-driven guide shows how to plan viability, proliferation, and cytotoxicity experiments with Coumestrol (SKU C5832), while distinguishing receptor pharmacology from the higher-concentration effects reported in rheumatoid arthritis fibroblast-like synoviocytes. It covers assay interpretation, solution handling, vendor selection, and evidence-based limits.
-
GABAB Antagonism in Astrocyte–Neuron Research
2026-09-25
A translational framework for using CGP 55845 hydrochloride to test GABAB-dependent contributions to synaptic signaling—while keeping astrocytic GAT-3 mechanisms and their evidential limits distinct.
-
EGTA and Calcium Causality in Neural Assays
2026-09-24
EGTA (egtazic acid) helps researchers test whether calcium availability is necessary for a cellular response—not which channel produced it. This article connects selective chelation to the interpretation of neural electrophysiology, injury models, and practical assay design.
-
Wortmannin: From PI3K Mechanism to Translation
2026-09-24
A mechanistic and translational guide to using Wortmannin to interrogate PI3K signaling, cancer biology, and viral entry—while accounting for its irreversible action, kinase cross-reactivity, and experimental limits.